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1. Introduction 
Although sequence analysis of nucleic acids con- 
taining Cthiouracil is hampered by the reactivity of 
the C:S group [l] , this feature can be used to convert 
4-thiouracil residues into stable N4methylcytidine 
residues labelled selectively with 14C. This finding has 
already been briefly reported [2] and follows the dis- 
covery that cytidine is formed by the action of Os04 
upon 4-thiouridine in the presence of NH3 [3]. This 
article provides the essential details of the procedure 
and of its use in studying the sequence around the 
4tU of tRNAphe from Escherichia cd. Independently, 
Ziff and Fresco [4] have applied a similar procedure 
with periodate as the oxidising agent o the study of 
valine tRNA. In this case, the sulphonate is known to 
be an intermediate [5]. Both methods are simple and 
adaptable to small-scale work. 0s04 does not attack 
the cisglycol at the 3’ terminus of the RNA and, un- 
der the conditions used, oxidation of ethylenic bonds 
of pyrimidines is very slight. The reaction with perio- 
date is influenced by the conformation of the tRNA 
[4] but this factor is less important in the 0s04 reacti- 
on. 
2. Makrials and methods 
Unfractionated tRNA from E. coli strain CA2%- 
Abbreviations: tRNA, unfractionated transfer RNA; tRNAPhe, 
phenylaianine accepting tRNA; G,U,A,C, 4mC, 4tU, the 3’- 
phosphates of guanosine, uridine, adenine, cytidine, N-4-m* 
thylcytkline and 4-thiouridine respectively. In the figs. B is 
xylene cyan01 F.F.used as a marker in ionophoresis and M is 
4mC. 
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was prepared at the Microbiological Research Esta- 
blishment, Porton. The tRNAphe was prepared at Oak 
Ridge National Laboratory from E. coli B and was 65% 
pure [6] . Prostatic phosphomonoesterase nd Os04 
solutions were as described earlier [3]. RNAsse T, was 
from the Sankyo Corp., spleen exonuclease from 
Worthington Biochemicals, and l*-methylamine 
from the Radiochemical Centre, Amersham. Nuclease 
digestions were performed according to Sanger and 
Brownlee [7] except that longer incubation times were 
required, probably because of the residual osmium in 
the modified RNA. The nucleosides were examined by 
paper chromatography in aq. 70% (v/v) propan-2-ol 
and in propan-2-ol/conc.HCl/water (13:4:2) by vol. 
3. Conversion of 4-thiouridine into N-4methylcytidine 
Previous reaction conditions for the formation of 
cytidine by Os04 and NH3 were used [3] except that 
NH3 was replaced by lower concentrations of methyla- 
mine hydrochloride buffers. The product was charac- 
terized by paper chromatography and UV spectropho- 
tometry and yields were about 80% based on e33 1 = 
2.1 X 104 for 4-thiouridine [8,9]. Unprotonated 
CH3NH2 is like NH3 in forming a complex with 0s04 
which is an active oxidising agent. Although 0.05 M 
CH3NH2 is oxidised by adding 0s04, the rate ap- 
pears to obey the equation u = k [Os04 ] [ CH3NH2] 3. 
Hence this side reaction is not important in the reac- 
tion mixtures used which contained less than 10 n&l 
0~04 and 5 mM unprotonated CH3NH2. 
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3. Modification of 4-thiouridine residues in tRNA 
In trial experiments, tRNA was treated with 0s04 
in aqueous l4 C-methylamine and the radioactivity 
was measured after precipitation by acid collection on 
membrane filters. The following conditions were even- 
tually adopted: 1.0 mg of tRNA was dissolved in 70 
~1 of a solution containing 20 mM 14C-methylamine 
(10 mCi/mmole) and 16 mM HCl. 0~04 (10 ~1 of an 
aqueous 90 mM solution) was added. At this stage 
the pH was 8.0. After incubation for 1 hr at 37”C, 
residual osmium compounds were reduced by adding 
10 1.t1 of 2-mercaptoethanol and incubating for a fur- 
ther 10 min. The RNA was then precipitated by ad- 
ding ethanol plus ammonium acetate, centrifuged and 
freeze dried. 
Alkaline hydrolysis and paper ionophoresis at pH 
3.5 showed a radioactive spot migrating just faster 
than C and identified as 4mC by treating with phos- 
phomonoesterase and cochromatography with nucleo- 
sides on paper. The amount of 14C in the 4mC showed 
that approximately 1mole of this nucleotide was for- 
med per mole of tRNA. Although much additional 
14C was smeared along the ionophoresis papers, this 
labelling appeared to be spurious and was lost during 
two-dimensional ionophoresis on cellulose acetate at 
pH 3.5 and DEAE-paper in 7% formic acid [7]. The 
4mC remained as the main spot just ahead of C in 
both dimensions and there was some 14C at the origin, 
Pancrrot~ RNase digest of ~4C!-.ethylated tWA 
t 
pH35 
7% formic acid 
(DEAE) 
* 
mam sQots from 
unfroctlonotcd 
tRNA 
Fig. 1. Diagram showing positions of radioactive spots and the 
structures assigned to them in two$mensional separations of 
pancreatic RNAase digests. M isN4-methylcytidylic acid. 
plus a faint spot near the position of A. The same pat- 
tern was given by tRNAPhe. 
Digests of modified unfractionated tRNA with pan- 
creatic RNAase A gave two main spots in positions 
expected for A4mC and G4mC with less intense 4mC 
and AA4mC spots (fig. 1). T1-RNAase gave main 
spots in positions expected for 4mCG and (4mCA)G. 
Elution of the latter spot and treatment with pancrea- 
tic RNAase, showed that A4mCG was virtually absent. 
One spot was given in each of the two types of nu- 
clease digest of tRNAP he. The structures were deduced 
by adding spleen exonuclease to the endonuclease di- 
gests and continuing the incubations for different 
periods of time before ionophoresis on DEAE-paper 
at pH 1.9 (fig. 3). From the relative mobilities of nu- 
cleotides in this system [7] and assuming that no unu- 
sual nucleotides are present apart from 4mC, the pan- 
creatic RNAase product is GGA4mC and this is con- 
sistent with its position in fig. 1. On the same assump 
Fig. 2. Autoradiograph of two-dimensional separation of T1 
digest of modified tRNA. The broken circle shows the posi- 
tion of a minor spot which coincides on ionophoresis with the 
single spot from tRNAPhe. A.,C,U and G, are marker 2’,3’-mo 
nonucleotides. B is the blue dye marker. Spot 1 is 4mCG and 
spot 2 is 4mCAG. 
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Fig. 3. Diagram of one-dimensional separation on DEAE-paper at pH 1.9. The broken circles in digest 7 indicate compounds re- 
leased on digestion for 7 hr, apparently by a contaminating activity in the Tl-RNAase preparation. Enzymes used for digestion 
are indicated as follows: “Pant” = pancreatic ribonuclease. ‘Tl” = rlbonuclease Tl . “spleen” = spleen exonuclease. 
tion, the T1 product is A4mCAG since, (i) its mobili- 
ties exclude extra C, A or U nucleotides, (ii) A4mC is 
released by pancreatic RNAase, (iii) no 4mCG was ob- 
served in any digest, (iv) a product with ae mobility 
of 4mCAG is released by the T, and spleen enzymes 
acting together. (The appearance of the latter material 
on prolonged digestion with the Tr-preparation alone 
is presumably due to a contaminating enzyme). The 
two structures indicate an original sequence pyrimidi- 
neGGA4tUAG which occurs in the complete structure 
given by Barrel1 and &urger [l] . The results obtained 
in the present work are not compatible with the se- 
quence CA4tUC(C)AG that has also been reported for 
the 4tU region of tRNAPhe [lo,1 l] . 
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